Lack of ECG effects of BMS-986165, an oral, selective tyrosine kinase 2 (TYK2) inhibitor: results from a thorough QT study in healthy subjects

Authors
Publication date
9 November 2019
Publisher
National Society for Cutaneous Medicine
Doi

    Abstract

    Abstract not available.</jats:p

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Crossref

      redirect
      oaiinfo:doi/10.25251%2Fskin.3.sup...
      Last time updated on 10/03/2025